PharmD CandidateUniversity of North Carolina Eshelman School of PharmacyChapel Hill, North Carolina, United States
PB0579 - Safety of continuous long term antifibrinolytic therapy in patients with Hereditary Hemorrhagic Telangiectasia
Monday, June 24, 202413:45 – 14:45 ICT